Infection & Immunity
Webcasts
How genomic medicine is transforming healthcare
Imagine a world where your unique genetic makeup can be used to tailor your medical care, and where illnesses and disease are treated with pinpoint accuracy.
Health
New non-profit targets under-researched diseases
McGillians are playing key roles in Conscience, a new non-profit initiative that hopes to use artificial intelligence and a “team sport” approach to encourage research into the rare diseases and potential threats that Big Pharma tends to ignore.
Health
The dazzling potential of RNA therapies
The success of the COVID-19 mRNA vaccines underlines the immense promise of RNA science. About 100 McGill scientists are actively pursuing research in this field, including some who have already done pioneering work. A recent agreement with Moderna could pave the way for new breakthroughs.
Discovery
The quest for a low-cost ventilator for the world
Even before COVID, “there were already a lot of people dying every year from the lack of ventilators,” says Reza Farivar, MSc’02, PhD’08. Together with the Montreal General Hospital Foundation, the McGill Engine, and others, he is leading an ambitious effort to change that.
Health
Tracking the spread of SARS CoV-2 in the U.S.
Duncan MacCannell, BSc’98, heads a national consortium in the U.S. that will use the combined genomics expertise of federal agencies, state labs, universities and medical science firms to trace the spread of SARS-CoV-2.
People
Protecting the population’s health North of 60
Kami Kandola, MDCM'92, fell in love with the north following her residency rotations in Northern Quebec. Today, she is leading the charge against COVID-19 in the Northwest Territories as its chief public health officer.
Discovery
The case for Solidarity in the battle against COVID-19
In February, as the evidence mounted that SARS-CoV-2, the virus responsible for COVID-19, was spreading to a growing number of countries across the globe, a select group of medical experts travelled to the World Health Organization's headquarters in Geneva, Switzerland, for a special planning session.
Discovery
New wave of McGill research projects supported by MI4 Fund
Wondering what progress is being made toward developing effective COVID-19 vaccines? Curious about the psychological impact of the pandemic? McGill researchers are on the case, with support from the MI4 Emergency COVID-19 Research Fund.
Discovery
In search of an effective COVID-19 treatment
As an anxious world waits for news about effective treatments for COVID-19, a global network of researchers is working together to hone in on the most promising drugs, and McGill’s Matthew Cheng, MDCM’11, is leading one of those key research projects.
Discovery
Emergency fund supports MI4 research on COVID-19
Sixteen McGill research projects examining different facets of the coronavirus pandemic have received vital funding support, thanks to the MI4 Emergency COVID-19 Research Funding program. The new initiative aims to support promising research efforts as quickly as possible.
Discovery
Confronting a killer
Tuberculosis has largely been tamed in the West, but it’s still the deadliest infectious disease in the world, killing 1.6 million last year. The international community is turning its attention to the menace of TB and a research centre at McGill is already playing a major role.
Discovery
Unlocking the power of our immune systems
Thanks to a $15-million gift from the Doggone Foundation, the University is launching the McGill Interdisciplinary Initiative in Infection and Immunity. The unique McGill/MUHC partnership involves 250 researchers.